Residual host cell DNA in biological preparations (recombinant protein drugs, antibody drugs, vaccines, cell therapy products, etc.) may pose infectious or tumorigenic risks, and it is necessary to control the residual DNA of host cells to an acceptable level. Host cell residual DNA testing can ensure that biological preparations meet the requirements of regulatory agencies such as China, WHO, Europe, and the United States. It is recommended to conduct host cell DNA residue research on process samples, and put the host cell DNA residue detection into the stock solution or preparation release inspection. The 2020 edition of "Chinese Pharmacopoeia" Part 3 - 3407 Exogenous DNA Residue Determination Method includes the qPCR method for the detection of host residual DNA in biological products. This method has the characteristics of rapidity, high throughput, and high sensitivity.
The global Host Cell Residual DNA Detection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
At present, various biological products have been widely used in the prevention and treatment of diseases, especially since the outbreak of the new crown epidemic, more efforts have been made in the screening of therapeutic drugs and the development of vaccines. Vaccines, antibody drugs, recombinant proteins and other products in biological products are expressed and produced on continuously passaged strains/cell lines. Although they have undergone strict purification processes, there may still be residual DNA fragments of host cells in the products , and these residual DNA will not only reduce the effectiveness of biological products, but also have the risk of infectivity and tumorigenicity. Therefore, considering the effectiveness requirements and safety of biological products, the residual DNA of host cells is the top priority of various quality control standards. Drug regulatory agencies in various countries have strict limit control on the content of residual DNA in host cells, and also provide a variety of classic detection methods. Establishing a suitable detection method for residual DNA in host cells is crucial for monitoring the safety and quality controllability of biological products. Among them, the qPCR method has become the preferred detection method for process research and product quality control of biological products because of its high sensitivity, specificity, accuracy and durability.
This report aims to provide a comprehensive presentation of the global market for Host Cell Residual DNA Detection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Host Cell Residual DNA Detection.
Report Scope
The Host Cell Residual DNA Detection market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Host Cell Residual DNA Detection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Host Cell Residual DNA Detection companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Âé¶¹Ô´´ Segmentation
By Company
Charles River
Thermo Fisher Scientific Inc
Cygnus Technologies
FUJIFILM Wako Pure Chemical Corporation
QIAGEN
Roche CustomBiotech
TransGen Biotech Co., Ltd
Bio-Rad
Vazyme
Creative Biogene
Bio-Rad Laboratories, Inc.
Jiangsu Cowin Biotech Co.,Ltd
RayKol Group Corp., Ltd
Jiangsu Hillgene Biopharma Co.,Ltd
ExCell Bio Group
Yeasen Biotechnology (Shanghai) Co., Ltd
Nanjing Vazyme Biotech Co.,Ltd
Wuhan Hzymes Biotechnology Co., Ltd
Shanghai Jinbo Biotechnology Co., Ltd
HZSKBIO
TransGen Biotech Co., Ltd
Segment by Type
DNA Probe Hybridization
Fluorescent Staining
Threshold Method
Immunoenzyme
qPCR Method
Segment by Application
Hospital
Clinic
Research Institutions
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Host Cell Residual DNA Detection companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Âé¶¹Ô´´ Analysis by Type
1.2.1 Global Host Cell Residual DNA Detection Âé¶¹Ô´´ Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 DNA Probe Hybridization
1.2.3 Fluorescent Staining
1.2.4 Threshold Method
1.2.5 Immunoenzyme
1.2.6 qPCR Method
1.3 Âé¶¹Ô´´ by Application
1.3.1 Global Host Cell Residual DNA Detection Âé¶¹Ô´´ Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Research Institutions
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Host Cell Residual DNA Detection Âé¶¹Ô´´ Perspective (2019-2030)
2.2 Host Cell Residual DNA Detection Growth Trends by Region
2.2.1 Global Host Cell Residual DNA Detection Âé¶¹Ô´´ Size by Region: 2019 VS 2023 VS 2030
2.2.2 Host Cell Residual DNA Detection Historic Âé¶¹Ô´´ Size by Region (2019-2024)
2.2.3 Host Cell Residual DNA Detection Forecasted Âé¶¹Ô´´ Size by Region (2025-2030)
2.3 Host Cell Residual DNA Detection Âé¶¹Ô´´ Dynamics
2.3.1 Host Cell Residual DNA Detection Industry Trends
2.3.2 Host Cell Residual DNA Detection Âé¶¹Ô´´ Drivers
2.3.3 Host Cell Residual DNA Detection Âé¶¹Ô´´ Challenges
2.3.4 Host Cell Residual DNA Detection Âé¶¹Ô´´ Restraints
3 Competition Landscape by Key Players
3.1 Global Top Host Cell Residual DNA Detection Players by Revenue
3.1.1 Global Top Host Cell Residual DNA Detection Players by Revenue (2019-2024)
3.1.2 Global Host Cell Residual DNA Detection Revenue Âé¶¹Ô´´ Share by Players (2019-2024)
3.2 Global Host Cell Residual DNA Detection Âé¶¹Ô´´ Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Host Cell Residual DNA Detection Revenue
3.4 Global Host Cell Residual DNA Detection Âé¶¹Ô´´ Concentration Ratio
3.4.1 Global Host Cell Residual DNA Detection Âé¶¹Ô´´ Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Host Cell Residual DNA Detection Revenue in 2023
3.5 Host Cell Residual DNA Detection Key Players Head office and Area Served
3.6 Key Players Host Cell Residual DNA Detection Product Solution and Service
3.7 Date of Enter into Host Cell Residual DNA Detection Âé¶¹Ô´´
3.8 Mergers & Acquisitions, Expansion Plans
4 Host Cell Residual DNA Detection Breakdown Data by Type
4.1 Global Host Cell Residual DNA Detection Historic Âé¶¹Ô´´ Size by Type (2019-2024)
4.2 Global Host Cell Residual DNA Detection Forecasted Âé¶¹Ô´´ Size by Type (2025-2030)
5 Host Cell Residual DNA Detection Breakdown Data by Application
5.1 Global Host Cell Residual DNA Detection Historic Âé¶¹Ô´´ Size by Application (2019-2024)
5.2 Global Host Cell Residual DNA Detection Forecasted Âé¶¹Ô´´ Size by Application (2025-2030)
6 North America
6.1 North America Host Cell Residual DNA Detection Âé¶¹Ô´´ Size (2019-2030)
6.2 North America Host Cell Residual DNA Detection Âé¶¹Ô´´ Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Host Cell Residual DNA Detection Âé¶¹Ô´´ Size by Country (2019-2024)
6.4 North America Host Cell Residual DNA Detection Âé¶¹Ô´´ Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Host Cell Residual DNA Detection Âé¶¹Ô´´ Size (2019-2030)
7.2 Europe Host Cell Residual DNA Detection Âé¶¹Ô´´ Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Host Cell Residual DNA Detection Âé¶¹Ô´´ Size by Country (2019-2024)
7.4 Europe Host Cell Residual DNA Detection Âé¶¹Ô´´ Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Host Cell Residual DNA Detection Âé¶¹Ô´´ Size (2019-2030)
8.2 Asia-Pacific Host Cell Residual DNA Detection Âé¶¹Ô´´ Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Host Cell Residual DNA Detection Âé¶¹Ô´´ Size by Region (2019-2024)
8.4 Asia-Pacific Host Cell Residual DNA Detection Âé¶¹Ô´´ Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Host Cell Residual DNA Detection Âé¶¹Ô´´ Size (2019-2030)
9.2 Latin America Host Cell Residual DNA Detection Âé¶¹Ô´´ Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Host Cell Residual DNA Detection Âé¶¹Ô´´ Size by Country (2019-2024)
9.4 Latin America Host Cell Residual DNA Detection Âé¶¹Ô´´ Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Host Cell Residual DNA Detection Âé¶¹Ô´´ Size (2019-2030)
10.2 Middle East & Africa Host Cell Residual DNA Detection Âé¶¹Ô´´ Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Host Cell Residual DNA Detection Âé¶¹Ô´´ Size by Country (2019-2024)
10.4 Middle East & Africa Host Cell Residual DNA Detection Âé¶¹Ô´´ Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Charles River
11.1.1 Charles River Company Detail
11.1.2 Charles River Business Overview
11.1.3 Charles River Host Cell Residual DNA Detection Introduction
11.1.4 Charles River Revenue in Host Cell Residual DNA Detection Business (2019-2024)
11.1.5 Charles River Recent Development
11.2 Thermo Fisher Scientific Inc
11.2.1 Thermo Fisher Scientific Inc Company Detail
11.2.2 Thermo Fisher Scientific Inc Business Overview
11.2.3 Thermo Fisher Scientific Inc Host Cell Residual DNA Detection Introduction
11.2.4 Thermo Fisher Scientific Inc Revenue in Host Cell Residual DNA Detection Business (2019-2024)
11.2.5 Thermo Fisher Scientific Inc Recent Development
11.3 Cygnus Technologies
11.3.1 Cygnus Technologies Company Detail
11.3.2 Cygnus Technologies Business Overview
11.3.3 Cygnus Technologies Host Cell Residual DNA Detection Introduction
11.3.4 Cygnus Technologies Revenue in Host Cell Residual DNA Detection Business (2019-2024)
11.3.5 Cygnus Technologies Recent Development
11.4 FUJIFILM Wako Pure Chemical Corporation
11.4.1 FUJIFILM Wako Pure Chemical Corporation Company Detail
11.4.2 FUJIFILM Wako Pure Chemical Corporation Business Overview
11.4.3 FUJIFILM Wako Pure Chemical Corporation Host Cell Residual DNA Detection Introduction
11.4.4 FUJIFILM Wako Pure Chemical Corporation Revenue in Host Cell Residual DNA Detection Business (2019-2024)
11.4.5 FUJIFILM Wako Pure Chemical Corporation Recent Development
11.5 QIAGEN
11.5.1 QIAGEN Company Detail
11.5.2 QIAGEN Business Overview
11.5.3 QIAGEN Host Cell Residual DNA Detection Introduction
11.5.4 QIAGEN Revenue in Host Cell Residual DNA Detection Business (2019-2024)
11.5.5 QIAGEN Recent Development
11.6 Roche CustomBiotech
11.6.1 Roche CustomBiotech Company Detail
11.6.2 Roche CustomBiotech Business Overview
11.6.3 Roche CustomBiotech Host Cell Residual DNA Detection Introduction
11.6.4 Roche CustomBiotech Revenue in Host Cell Residual DNA Detection Business (2019-2024)
11.6.5 Roche CustomBiotech Recent Development
11.7 TransGen Biotech Co., Ltd
11.7.1 TransGen Biotech Co., Ltd Company Detail
11.7.2 TransGen Biotech Co., Ltd Business Overview
11.7.3 TransGen Biotech Co., Ltd Host Cell Residual DNA Detection Introduction
11.7.4 TransGen Biotech Co., Ltd Revenue in Host Cell Residual DNA Detection Business (2019-2024)
11.7.5 TransGen Biotech Co., Ltd Recent Development
11.8 Bio-Rad
11.8.1 Bio-Rad Company Detail
11.8.2 Bio-Rad Business Overview
11.8.3 Bio-Rad Host Cell Residual DNA Detection Introduction
11.8.4 Bio-Rad Revenue in Host Cell Residual DNA Detection Business (2019-2024)
11.8.5 Bio-Rad Recent Development
11.9 Vazyme
11.9.1 Vazyme Company Detail
11.9.2 Vazyme Business Overview
11.9.3 Vazyme Host Cell Residual DNA Detection Introduction
11.9.4 Vazyme Revenue in Host Cell Residual DNA Detection Business (2019-2024)
11.9.5 Vazyme Recent Development
11.10 Creative Biogene
11.10.1 Creative Biogene Company Detail
11.10.2 Creative Biogene Business Overview
11.10.3 Creative Biogene Host Cell Residual DNA Detection Introduction
11.10.4 Creative Biogene Revenue in Host Cell Residual DNA Detection Business (2019-2024)
11.10.5 Creative Biogene Recent Development
11.11 Bio-Rad Laboratories, Inc.
11.11.1 Bio-Rad Laboratories, Inc. Company Detail
11.11.2 Bio-Rad Laboratories, Inc. Business Overview
11.11.3 Bio-Rad Laboratories, Inc. Host Cell Residual DNA Detection Introduction
11.11.4 Bio-Rad Laboratories, Inc. Revenue in Host Cell Residual DNA Detection Business (2019-2024)
11.11.5 Bio-Rad Laboratories, Inc. Recent Development
11.12 Jiangsu Cowin Biotech Co.,Ltd
11.12.1 Jiangsu Cowin Biotech Co.,Ltd Company Detail
11.12.2 Jiangsu Cowin Biotech Co.,Ltd Business Overview
11.12.3 Jiangsu Cowin Biotech Co.,Ltd Host Cell Residual DNA Detection Introduction
11.12.4 Jiangsu Cowin Biotech Co.,Ltd Revenue in Host Cell Residual DNA Detection Business (2019-2024)
11.12.5 Jiangsu Cowin Biotech Co.,Ltd Recent Development
11.13 RayKol Group Corp., Ltd
11.13.1 RayKol Group Corp., Ltd Company Detail
11.13.2 RayKol Group Corp., Ltd Business Overview
11.13.3 RayKol Group Corp., Ltd Host Cell Residual DNA Detection Introduction
11.13.4 RayKol Group Corp., Ltd Revenue in Host Cell Residual DNA Detection Business (2019-2024)
11.13.5 RayKol Group Corp., Ltd Recent Development
11.14 Jiangsu Hillgene Biopharma Co.,Ltd
11.14.1 Jiangsu Hillgene Biopharma Co.,Ltd Company Detail
11.14.2 Jiangsu Hillgene Biopharma Co.,Ltd Business Overview
11.14.3 Jiangsu Hillgene Biopharma Co.,Ltd Host Cell Residual DNA Detection Introduction
11.14.4 Jiangsu Hillgene Biopharma Co.,Ltd Revenue in Host Cell Residual DNA Detection Business (2019-2024)
11.14.5 Jiangsu Hillgene Biopharma Co.,Ltd Recent Development
11.15 ExCell Bio Group
11.15.1 ExCell Bio Group Company Detail
11.15.2 ExCell Bio Group Business Overview
11.15.3 ExCell Bio Group Host Cell Residual DNA Detection Introduction
11.15.4 ExCell Bio Group Revenue in Host Cell Residual DNA Detection Business (2019-2024)
11.15.5 ExCell Bio Group Recent Development
11.16 Yeasen Biotechnology (Shanghai) Co., Ltd
11.16.1 Yeasen Biotechnology (Shanghai) Co., Ltd Company Detail
11.16.2 Yeasen Biotechnology (Shanghai) Co., Ltd Business Overview
11.16.3 Yeasen Biotechnology (Shanghai) Co., Ltd Host Cell Residual DNA Detection Introduction
11.16.4 Yeasen Biotechnology (Shanghai) Co., Ltd Revenue in Host Cell Residual DNA Detection Business (2019-2024)
11.16.5 Yeasen Biotechnology (Shanghai) Co., Ltd Recent Development
11.17 Nanjing Vazyme Biotech Co.,Ltd
11.17.1 Nanjing Vazyme Biotech Co.,Ltd Company Detail
11.17.2 Nanjing Vazyme Biotech Co.,Ltd Business Overview
11.17.3 Nanjing Vazyme Biotech Co.,Ltd Host Cell Residual DNA Detection Introduction
11.17.4 Nanjing Vazyme Biotech Co.,Ltd Revenue in Host Cell Residual DNA Detection Business (2019-2024)
11.17.5 Nanjing Vazyme Biotech Co.,Ltd Recent Development
11.18 Wuhan Hzymes Biotechnology Co., Ltd
11.18.1 Wuhan Hzymes Biotechnology Co., Ltd Company Detail
11.18.2 Wuhan Hzymes Biotechnology Co., Ltd Business Overview
11.18.3 Wuhan Hzymes Biotechnology Co., Ltd Host Cell Residual DNA Detection Introduction
11.18.4 Wuhan Hzymes Biotechnology Co., Ltd Revenue in Host Cell Residual DNA Detection Business (2019-2024)
11.18.5 Wuhan Hzymes Biotechnology Co., Ltd Recent Development
11.19 Shanghai Jinbo Biotechnology Co., Ltd
11.19.1 Shanghai Jinbo Biotechnology Co., Ltd Company Detail
11.19.2 Shanghai Jinbo Biotechnology Co., Ltd Business Overview
11.19.3 Shanghai Jinbo Biotechnology Co., Ltd Host Cell Residual DNA Detection Introduction
11.19.4 Shanghai Jinbo Biotechnology Co., Ltd Revenue in Host Cell Residual DNA Detection Business (2019-2024)
11.19.5 Shanghai Jinbo Biotechnology Co., Ltd Recent Development
11.20 HZSKBIO
11.20.1 HZSKBIO Company Detail
11.20.2 HZSKBIO Business Overview
11.20.3 HZSKBIO Host Cell Residual DNA Detection Introduction
11.20.4 HZSKBIO Revenue in Host Cell Residual DNA Detection Business (2019-2024)
11.20.5 HZSKBIO Recent Development
11.21 TransGen Biotech Co., Ltd
11.21.1 TransGen Biotech Co., Ltd Company Detail
11.21.2 TransGen Biotech Co., Ltd Business Overview
11.21.3 TransGen Biotech Co., Ltd Host Cell Residual DNA Detection Introduction
11.21.4 TransGen Biotech Co., Ltd Revenue in Host Cell Residual DNA Detection Business (2019-2024)
11.21.5 TransGen Biotech Co., Ltd Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Charles River
Thermo Fisher Scientific Inc
Cygnus Technologies
FUJIFILM Wako Pure Chemical Corporation
QIAGEN
Roche CustomBiotech
TransGen Biotech Co., Ltd
Bio-Rad
Vazyme
Creative Biogene
Bio-Rad Laboratories, Inc.
Jiangsu Cowin Biotech Co.,Ltd
RayKol Group Corp., Ltd
Jiangsu Hillgene Biopharma Co.,Ltd
ExCell Bio Group
Yeasen Biotechnology (Shanghai) Co., Ltd
Nanjing Vazyme Biotech Co.,Ltd
Wuhan Hzymes Biotechnology Co., Ltd
Shanghai Jinbo Biotechnology Co., Ltd
HZSKBIO
TransGen Biotech Co., Ltd
Ìý
Ìý
*If Applicable.